These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2441481)

  • 1. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.
    Chang RS; Lotti VJ; Monaghan RL; Birnbaum J; Stapley EO; Goetz MA; Albers-Schönberg G; Patchett AA; Liesch JM; Hensens OD
    Science; 1985 Oct; 230(4722):177-9. PubMed ID: 2994227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L364718, a new CCK antagonist, on amylase secretion in isolated rat pancreatic acini.
    Hosotani R; Chowdhury P; McKay D; Rayford PL
    Pancreas; 1988; 3(1):95-8. PubMed ID: 2452436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718.
    Adrian TE; Zucker KA; Bilchik AJ; Modlin IM
    Int J Pancreatol; 1990 Jan; 6(1):61-9. PubMed ID: 1700032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.
    Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ
    J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gastrin receptors on guinea pig pancreatic acini.
    Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
    Wisner JR; Renner IG
    Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.
    Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H; Yazaki N; Endo T; Nagasaki M
    Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
    Kim H; Kim KH
    Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.